Transgender women are at a higher risk of anal cancer, though there is uncertain relationship to hormones and further research must be done.
Hillary Dunlevy, MD Advanced HRA Course Director
Are there any concerns for restarting hormone therapies following treatment for anal cancer?
John Stanton, DNP, MPH, AGPCN-BC, AAHIVS
The International Anal Neoplasia Society
P.O. Box 1543 Leesburg, Virginia 20177
info@iansociety.org